Skip to main content
Psychedelic State(s) of America
Live · TradingView

NEWS · COMMENTARY · ANALYSIS · EDUCATION

Psychedelic State(s) of America

Psychedelic State(s) of America is dedicated to empowering rigorously independent psychedelic news, commentary, analysis, and education across the United States and around the world.

Read the latestAbout PSA

Reporting as Seen In & Featured By

  • Forbes Magazine logo
  • GBH News Boston logo
  • NBC4 Washington logo
  • The Boston Globe logo
  • Boston Institute for Nonprofit Journalism logo
  • TJM Boston logo
  • DoubleBlind Magazine logo
  • PT Media & Podcast logo
  • MM Policy News logo
  • Lucid News logo
  • CTT Magazine logo
  • TD Policy logo
  • Hyphae Leaks logo
  • The Mycopreneur Podcast logo
  • Psy Guide logo
  • The Microdose logo
  • Tricycle Day logo
¿Hablas español?Visita PSA en español

Latest psychedelic news

News and commentary, newest first. Page 1 of 43.

All newsAll commentary
"Is Psychedelic Euphoria an Adverse Event?" - PSA's Sunday Sound-Off: October 25, 2026
PSA Media Partner7 min read

"Is Psychedelic Euphoria an Adverse Event?" - PSA's Sunday Sound-Off: October 25, 2026

Plus: Introducing PSA's Global Psychedelic Policy Tracker and as always, the PSA NewsWire Highlights of the Week

PSA Media Team
New study finds psilocybin addresses strong inflammatory signals associated with Parkinson's Disease.
Psychedelics3 min read

New study finds psilocybin addresses strong inflammatory signals associated with Parkinson's Disease.

Here's what you need to know

Noah Daly
The Ninety Days Nobody Wrote Down - PSA's Regulatory Dispatch, Vol. II
Commentary19 min read

The Ninety Days Nobody Wrote Down - PSA's Regulatory Dispatch, Vol. II

"An FDA approval does not produce a prescription for a psychedelic."

Odette Alina Hauke, M.S.
Need Some Psychedelic Advice? Introducing #AskAshley
5 min read

Need Some Psychedelic Advice? Introducing #AskAshley

A New Psychedelic Advice Column powered by PSA and The Psychedelic Guide Network focused on Bringing Ethics Into the Light

PSA Newsroom
"How Psychedelic Therapy is Used to Continue the US War Machine" - PSA's Sunday Sound-Off: October 18, 2026
Commentary29 min read

"How Psychedelic Therapy is Used to Continue the US War Machine" - PSA's Sunday Sound-Off: October 18, 2026

Plus: "Is the Liberation of Spirituality from Religion the great liberation of our time?" and the PSA NewsWire Highlights of the Week!

PSA Media Team
Hype, Hope, and Reality: Where the Movement Really Stands – LIVE in Houston Next Month with PsyT and PSA
PSA Media Partner2 min read

Hype, Hope, and Reality: Where the Movement Really Stands – LIVE in Houston Next Month with PsyT and PSA

Join PSA Founder Jack Gorsline at PsyT Houston on Saturday, November 7th for a candid look at where the psychedelic movement really stands.

PSA Newsroom

Commentary

Opinions and analysis from the PSA network. Page 1 of 14.

All op-eds
The Ninety Days Nobody Wrote Down - PSA's Regulatory Dispatch, Vol. II
Commentary19 min read

The Ninety Days Nobody Wrote Down - PSA's Regulatory Dispatch, Vol. II

"An FDA approval does not produce a prescription for a psychedelic."

Odette Alina Hauke, M.S.
"How Psychedelic Therapy is Used to Continue the US War Machine" - PSA's Sunday Sound-Off: October 18, 2026
Commentary29 min read

"How Psychedelic Therapy is Used to Continue the US War Machine" - PSA's Sunday Sound-Off: October 18, 2026

Plus: "Is the Liberation of Spirituality from Religion the great liberation of our time?" and the PSA NewsWire Highlights of the Week!

PSA Media Team
The Receipts and the Results: Louisiana's Ibogaine Trials - PSA's Regulatory Dispatch, Vol. 1
Commentary18 min read

The Receipts and the Results: Louisiana's Ibogaine Trials - PSA's Regulatory Dispatch, Vol. 1

Louisiana is funding ibogaine trials with opioid settlement money. The agreement governing that money requires someone to publish where every dollar went. The statute spending it requires nothing about what the trials find.

Odette Alina Hauke, M.S.
"Considerations for the FDA on Postpartum-depression, for the record" - PSA's Sunday Sound-Off: September 20th, 2026
Commentary5 min read

"Considerations for the FDA on Postpartum-depression, for the record" - PSA's Sunday Sound-Off: September 20th, 2026

"On Postpartum-depression, for the record: Considerations for the FDA," ICYMI: "What's the most pressing issue facing psychedelics in the U.S.?" plus the PSA NewsWire Highlights of the Week

Stephanie Karzon Abrams
PSA Newswire banner: an animated typewriter spelling out 'Psychedelic State(s) of America'

PSA Newswire

Weekly dispatches from across the psychedelic landscape, plus the latest stories moving on the wire.

See the full PSA Newswire

PSA NewsWire Highlights of the Week

📜 Law & Policy

Lucid News logoFrom our friends at Lucid News

Horizons 2026: New Medicines for an Old System

By Christine Redick

💊 Science & Research

Over at Vice News

This Breathing Exercise Could Make You Feel Like You’re Tripping on LSD. But Does It Actually Work?

By Luis Prada

🎨 Culture

From our friends at DoubleBlind

Did Ancient Buddhists Use Psychedelics?

By Danielle Simone Brand

💰 Business

Over at Canadian Affairs

Beyond veterans: The overlooked communities seeking psychedelic therapy

By Alexandra Keeler

Latest from the wire

Community

Upcoming psychedelic events

See the full calendar

Watch the Latest

Fresh video from the PSA YouTube channel.

Subscribe
Newsletter

Subscribe to Psychedelic State(s) of America

Subscribe TODAY to get the highest quality independent psychedelic journalism covering policy, science, culture, and more — no spam, unsubscribe anytime.

Topics you care about

Optional. Pick the beats you want flagged in your briefing.

Subscribe via RSS

Follow PSA

Independent psychedelic journalism, wherever you already spend your time.